Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000227

EVP & Chief Financial Officer sold 3,000 shares at $518.27 ($1,554,810)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

WAGNER CHARLES F JR · EVP & Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-11 Sale : show line 1 in the form 10b5-1 −3,000 $518.27 $1,554,810 44,137 D
Open-market sales · 3,000 sh · avg $518.27 · $1,554,810
Loading xslF345X05/wk-form4_1731532506.xml…